Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Science 37 Hldgs Inc (NQ: SNCE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Science 37 Hldgs Inc

< Previous 1 2 3 4 5 Next >
Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance
Science 37’s Virtual Site Model for Clinical Research Impresses in First-of-its-Kind FDA Inspection 
From Science 37, Inc.
Via GlobeNewswire
Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”
From Science 37, Inc.
Via GlobeNewswire
Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial
Partnership with Leading Biotech Company Enrolls 28% of Study Participants with 22x Greater Enrollment Velocity Compared to Traditional Brick-and-Mortar Clinical Trial Sites 
From Science 37, Inc.
Via GlobeNewswire
Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment
New patent-protected, central recruitment leverages the Science 37 Metasite™ to accelerate enrollment and dramatically reduce site burden 
From Science 37, Inc.
Via GlobeNewswire
SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE
From Kahn Swick & Foti, LLC
Via Business Wire
SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE
From Kahn Swick & Foti, LLC
Via Business Wire
Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. The Dow traded up 0.03% to 38,121.11 while the NASDAQ rose 0.48% to... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped... 
Via Benzinga
SNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Science 37 Holdings, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: McGrath RentCorp (Nasdaq – MGRC), Science 37 Holdings, Inc. (Nasdaq – SNCE), Eagle Bulk Shipping Inc. (NYSE - EGLE), Cerevel Therapeutics Holdings, Inc. (Nasdaq –
From Brodsky & Smith LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
Science 37 stockholders to receive $5.75 per share in cash 
From Science 37, Inc.
Via GlobeNewswire
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
SNCE Stock Earnings: Science 37 Hldgs Beats EPS, Beats Revenue for Q1 2023
SNCE stock results show that Science 37 Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2023. 
Via InvestorPlace
SNCE Stock Earnings: Science 37 Hldgs Beats EPS, Beats Revenue for Q2 2023
SNCE stock results show that Science 37 Hldgs beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2023. 
Via InvestorPlace
SNCE Stock Earnings: Science 37 Hldgs Beats EPS, Beats Revenue for Q3 2023
SNCE stock results show that Science 37 Hldgs beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023. 
Via InvestorPlace
Science 37 Receives Top Honors in Everest PEAK Matrix®
Science 37 emerges as the only clinical trial site to be recognized as a Leader in Decentralized Clinical Trials 
From Science 37, Inc.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the trading week with a look at the biggest pre-market stock movers worth watching for Monday morning! 
Via InvestorPlace
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Science 37, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Third Quarter 2023 Financial Results
From Science 37, Inc.
Via GlobeNewswire
Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Science 37, Inc.
Via GlobeNewswire
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
Via Benzinga
Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List
From Science 37, Inc.
Via GlobeNewswire
Science 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023
From Science 37, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.